Publication year
2003Source
Neuroscience Letters, 338, 3, (2003), pp. 177-180ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
SW OZ DCC SMN
Anesthesiology
Former Organization
SW OZ NICI BI
Journal title
Neuroscience Letters
Volume
vol. 338
Issue
iss. 3
Page start
p. 177
Page end
p. 180
Subject
Cognitive neuroscienceAbstract
The antiepileptic drug vigabatrin increases GABA concentrations by inhibiting GABA transaminase. The effects of vigabatrin on type 11 spike wave discharges (SWDs) in the electroencephalogram of ACI rats were studied in order to learn more about the effects of altering GABA concentration on SWDs. The incidence of type II SWDs increased after vigabatrin (60/h) as compared to saline treatment (3.7/h). This effect appeared with a halftime of 100 min. The duration of type II SWDs increased after vigabatrin (1.52 s) as compared to saline treatment (1.04 s), but the peak-frequency of the type 11 SWDs decreased after vigabatrin (5.6 Hz) as compared to saline treatment (7.5 Hz). Thus, vigabatrin alters the type II SWD morphology. These results are in agreement with predictions of Destexhe's theoretical model, modulating both GABA(A) and GABA(B) conductances.
This item appears in the following Collection(s)
- Academic publications [226905]
- Faculty of Medical Sciences [86456]
- Faculty of Social Sciences [28469]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.